The results showed that p-stage (P < 0.0001), tumor differentiation grade (P = 0.0013), and age (P = 0.043) were confounding factors for TROP2 expression in lung cancer-specific survival (Supplementary Table 1). Here, TACSTD2 is linked to lung carcinoma.